Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



FALBERG KATHRYN E Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Gifted 50,504 shares @ $0
Granted 6,800 shares @ $0
Granted 19,500 options to buy @ $19.6, valued at $382.2k
05/30/2023 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Trade Desk, Inc.
Txns: Granted 4,238 shares @ $0
Granted 799 shares @ $62.52, valued at $50k
05/17/2023 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 366,744 options to buy @ $1.64, valued at $601.5k
02/08/2023 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Trade Desk, Inc.
Txns: Disposed/sold 21 shares @ $59.83, valued at $1.3k
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Tricida, Inc.
Txns: Granted 27,207 options to buy @ $9.87, valued at $268.5k
06/16/2022 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 4,100 shares @ $0
Granted 16,800 options to buy @ $20.62, valued at $346.4k
05/31/2022 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Trade Desk, Inc.
Txns: Granted 4,178 shares @ $0
Granted 835 shares @ $59.83, valued at $50k
Granted 267 shares @ $59.83, valued at $16k
Granted 83 shares @ $59.83, valued at $5k
05/18/2022 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 118,784 options to buy @ $4.05, valued at $481.1k
11/23/2021 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Trade Desk, Inc.
Txns: Sold 80,563 shares @ $108.03, valued at $8.7M
Sold 47,719 shares @ $108.9, valued at $5.2M
Sold 21,468 shares @ $109.98, valued at $2.4M
Sold 250 shares @ $110.44, valued at $27.6k
11/02/2021 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 45,229 options to buy @ $9.17, valued at $414.7k
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2021 4 FALBERG KATHRYN E (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $17.98, valued at $179.8k
06/07/2021 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 3,000 shares @ $0
Granted 14,100 options to buy @ $24.79, valued at $349.5k
06/01/2021 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Trade Desk, Inc.
Txns: Granted 390 shares @ $0
Granted 78 shares @ $639.65, valued at $49.9k
Granted 25 shares @ $639.65, valued at $16k
Granted 7 shares @ $639.65, valued at $4.5k
04/02/2021 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Bought 20,000 shares @ $28.3498, valued at $567k
02/12/2021 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 239,361 options to buy @ $4.6, valued at $1.1M
11/23/2020 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Trade Desk, Inc.
Txns: Converted 20,000 shares @ $0
Sold 232 shares @ $806.63, valued at $187.1k
Sold 795 shares @ $807.84, valued at $642.2k
Sold 1,853 shares @ $809.03, valued at $1.5M
Sold 2,852 shares @ $810.19, valued at $2.3M
Sold 5,670 shares @ $811, valued at $4.6M
Sold 200 shares @ $811.68, valued at $162.3k
Sold 891 shares @ $813.04, valued at $724.4k
Sold 10 shares @ $814, valued at $8.1k
Sold 1,891 shares @ $815, valued at $1.5M
Sold 4,139 shares @ $818.15, valued at $3.4M
10/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2020 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Tricida, Inc.
Txns: Granted 5,670 shares @ $0
Granted 22,967 options to buy @ $25.4, valued at $583.4k
06/10/2020 4 FALBERG KATHRYN E (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $28.24, valued at $282.4k
06/08/2020 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 3,000 shares @ $0
Granted 14,000 options to buy @ $30.05, valued at $420.7k
05/29/2020 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Granted 7,840 shares @ $0
Granted 15,398 options to buy @ $17.11, valued at $263.5k
05/28/2020 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Trade Desk, Inc.
Txns: Granted 901 shares @ $0
Granted 180 shares @ $249.66, valued at $44.9k
Granted 64 shares @ $249.66, valued at $16k
Granted 20 shares @ $249.66, valued at $5k
11/13/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2019 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Bought 12,935 shares @ $8.5158, valued at $110.2k
06/13/2019 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Bought 10,000 shares @ $7.9, valued at $79k
Bought 10,000 shares @ $8.4928, valued at $84.9k
06/11/2019 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Bought 22,065 shares @ $7.9899, valued at $176.3k
Bought 10,000 shares @ $8.25, valued at $82.5k
06/10/2019 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 35,000 options to buy @ $7.99, valued at $279.7k
06/05/2019 4 FALBERG KATHRYN E (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $34.83, valued at $348.3k
06/04/2019 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Tricida, Inc.
Txns: Granted 1,879 shares @ $0
Granted 7,068 options to buy @ $36.74, valued at $259.7k
05/28/2019 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Gifted 69,894 shares @ $0
Gifted 69,894 shares @ $0
Granted 6,442 shares @ $0
Granted 11,432 options to buy @ $19.9, valued at $227.5k
05/02/2019 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Trade Desk, Inc.
Txns: Granted 1,086 shares @ $0
Granted 217 shares @ $207.03, valued at $44.9k
Granted 48 shares @ $207.03, valued at $9.9k
Granted 77 shares @ $207.03, valued at $15.9k
03/13/2019 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Trade Desk, Inc.
Txns: Sold 40,000 shares @ $205.4741, valued at $8.2M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy